Journal article
ADGRV1 is implicated in myoclonic epilepsy
KA Myers, S Nasioulas, A Boys, JM McMahon, H Slater, P Lockhart, D du Sart, IE Scheffer
Epilepsia | WILEY | Published : 2018
DOI: 10.1111/epi.13980
Abstract
Objective: To investigate the significance of variation in ADGRV1 (also known as GPR98, MASS1, and VLGR1), MEF2C, and other genes at the 5q14.3 chromosomal locus in myoclonic epilepsy. Methods: We studied the epilepsy phenotypes of 4 individuals with 5q14.3 deletion and found that all had myoclonic seizures. We then screened 6 contiguous genes at 5q14.3, MEF2C, CETN3, MBLAC2, POLR3G, LYSMD3, and ADGRV1, in a 95-patient cohort with epilepsy and myoclonic seizures. Of these genes, point mutations in MEF2C cause a phenotype involving seizures and intellectual disability. A role for ADGRV1 in epilepsy has been proposed previously, based on a recessive mutation in the Frings mouse model of audiog..
View full abstractGrants
Awarded by State Government of Victoria
Funding Acknowledgements
Australian National Health and Medical Research Council Program, Grant/Award Number: 628952, 437027, GNT1032364; Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS